Structure, Stability, Spectroscopy and Chemical Bonding Analyses on the Novel X 6 (X = N, P, As, Sb, Bi) Molecules
Journal of Computational Chemistry · 15.08.2026 · 47 (22)
DOI: 10.1002/jcc.70479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computational Chemistry, online erschienen am 11.08.2026. Verfasst von Yu Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Rare Earths, University of Science and Technology of China, Hefei, China. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Inspired by the successful synthesis of zig‐zag C 2h ‐N 6 ( Nature 2025 , 642, 356–360), we systematically explored the structure, stability, infrared spectroscopy, chemical bonding and weak interaction of novel X 6 (X = N, P, As, Sb, Bi) molecules using relativistic DFT and CCSD(T) method. The results of global‐minimum structural searches indicate the N 6 prefers a trimer‐like C 3 geometry, while P 6 /As 6 tends to form the bag‐like C 2v structure, and Sb 6 /Bi 6 prefers the triangular prism D 3h structure energetically instead. Simulated infrared spectra reveal the trimer‐like N 6 exhibiting an isolated high‐frequency triple‐bond stretching band far separated from the low‐frequency single‐bond skeletal vibration regimes of heavier pnictogen hexamers. Canonical molecular orbital analyses reveal a non‐monotonic periodic evolution of HOMO–LUMO electronic band gaps, with N 6 , Sb 6 and Bi 6 possessing substantially wider frontier orbital energy separation relative to narrow‐gap bag‐like P 6 and As 6 species. Multi‐modal wavefunction analytical tools including AdNDP, QTAIM, ELF, IRI and RDG/NCI resolve continuous periodic evolution of covalent bonding motifs from discrete diatomic triple bonds in N 6 , mixed σ and π bonding in P 6 and As 6 , to pure localized σ single‐bonded frameworks devoid of π orbital contributions in Sb 6 and Bi 6 . Quantified dissociation energy values for two representative uni‐molecular fragmentation pathways demonstrate monotonically increasing resistance to full decomposition from N 6 to Bi 6 . Additional SOC‐CASSCF energy level calculations further quantify the progressive intensification of spin‐orbit coupling relativistic effects down group 15, which exert negligible electronic perturbation on N 6 and P 6 , moderate orbital splitting for As 6 , and decisive rearrangement of frontier orbital manifolds for Sb 6 and Bi 6 that dictates geometric stability preferences of heavy hexamer prism. This work systematically reveals the periodic evolution law of group VA X 6 molecules, providing key theoretical insights for the design and synthesis of novel pnictogen clusters.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Rare Earths, University of Science and Technology of China, Hefei, China.
- Fundamental Science Center of Rare Earths, Ganjiang Innovation Academy, Chinese Academy of Sciences, Ganzhou, Jiangxi, China.
ORCID-Profile: Yang-Yang Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Cheng, Y., Zhang, S. W., Dai, X. Y., & Zhang, Y. Y. (2026). Structure, Stability, Spectroscopy and Chemical Bonding Analyses on the Novel X 6 (X = N, P, As, Sb, Bi) Molecules. Journal of Computational Chemistry, 47(22). https://doi.org/10.1002/jcc.70479
Vancouver
Cheng Y, Zhang SW, Dai XY, Zhang YY. Structure, Stability, Spectroscopy and Chemical Bonding Analyses on the Novel X 6 (X = N, P, As, Sb, Bi) Molecules. Journal of Computational Chemistry. 2026;47(22). doi:10.1002/jcc.70479
BibTeX
@article{Cheng2026,
author = {Cheng, Yu and Zhang, Shu-Wen and Dai, Xin-Yu and Zhang, Yang-Yang},
title = {Structure, Stability, Spectroscopy and Chemical Bonding Analyses on the Novel X 6 (X = N, P, As, Sb, Bi) Molecules},
journal = {Journal of Computational Chemistry},
year = {2026},
volume = {47},
number = {22},
doi = {10.1002/jcc.70479}
}
EUVIMED